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Abstract
Background: The glucokinase regulatory protein encoded by GCKR plays an important role in glucose metabolism and a
single nucleotide polymorphism (SNP) rs1260326 (P446L) in the gene has been associated with several age-related
biomarkers, including triglycerides, glucose, insulin and apolipoproteins. However, associations between SNPs in the gene
and other ageing phenotypes such as cognitive and physical capability have not been reported.
Methods: As part of the Healthy Ageing across the Life Course (HALCyon) collaborative research programme, men and
women from five UK cohorts aged between 44 and 90+ years were genotyped for rs1260326. Meta-analysis was used to
pool within-study genotypic associations between the SNP and several age-related phenotypes, including body mass index
(BMI), blood lipid levels, lung function, and cognitive and physical capability.
Results: We confirm the associations between the minor allele of the SNP and higher triglycerides and lower glucose levels.
We also observed a triglyceride-independent association between the minor allele and lower BMI (pooled beta on z-
score =20.04, p-value = 0.0001, n = 16,251). Furthermore, there was some evidence for gene-environment interactions,
including physical activity attenuating the effects on triglycerides. However, no associations were observed with measures
of cognitive and physical capability.
Conclusion: Findings from middle-aged to older adults confirm associations between rs1260326 GCKR and triglycerides and
glucose, suggest possible gene-environment interactions, but do not provide evidence that its relevance extends to
cognitive and physical capability.
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Introduction
The ageing process is complex, comprising several mechanisms
and resulting in increased frailty and disease susceptibility [1].
Despite there being no single dominant mechanism of ageing,
there are several reported associations observed among age-related
phenotypes [2–5], suggesting phenotypes may directly or indirectly
affect others and/or that distinct phenotypes may be affected by
common causes [6]. For instance, associations observed between
cognitive and physical performance in older adults [2,4] may be
indicative of genetic factors influencing age-related diseases that
lead to the impairment of both sets of indicators or of direct
genetic effects on the indicators [6]. Whilst not all studies [7]
support a common cause hypothesis for ageing phenotypes [8,9],
there are some genes that appear to influence multiple age-related
traits.
GCKR (glucokinase (hexokinase 4) regulator) is one such gene
with potentially pleiotropic effects. Encoding the glucokinase
regulatory protein that regulates the activity of glucokinase (GCK),
a regulator of glucose, a non-synonymous [10] single nucleotide
polymorphism (SNP), rs1260326 (P446L), in the gene appears to
be functional, inhibiting GCK activity in the liver [11]. This
property has several phenotypic manifestations, with many reports
of the T allele of the SNP being associated with increased levels of
triglycerides[10,12–14], in addition to increased C-reactive protein
(CRP) [15], factor VII [16], apolipoproteins [12,13], albumin
[17], creatinine [18], protein C [19] and uric acid [20], as well as
lower levels of insulin [21] and fasting glucose [10,22] in candidate
gene and genome-wide association studies (GWAS). SNPs in
strong linkage disequilibrium with the variant have also been
associated with serum calcium [23] and risk of Crohn’s disease
[24]. Furthermore, these genotypic associations may be environ-
mentally influenced as there is evidence that an intensive lifestyle
intervention, including increased physical activity, may reduce the
effects of rs1260326 on triglyceride levels [25].
Given the hypothesised relationships between some of these
biomarkers and other important age-related phenotypes, such as
physical and cognitive performance [5,26], we hypothesised that
GCKR may also be relevant to the capacity to undertake the
physical and mental tasks of daily living. Indicators of physical
capability, including grip strength, decline from mid-life [27] and
have been associated with morbidity [28] and mortality [29] rates.
The substantial heritability estimates for these indicators [30,31]
suggest genetic variants may contribute to their inter-individual
variability. Measures of cognitive capability, such as verbal
fluency, also have a substantial genetic component [30,32] and
show associations with mortality rate; though these associations
may be partly explained by lifestyle and socioeconomic factors
[33,34]. We conducted analyses on 16,251 participants aged
between 44 and 90+ from five UK cohorts as part of the
HALCyon research programme (Healthy Ageing across the Life
Course; www.halcyon.ac.uk) to investigate associations between
rs1260326 (GCKR) and several age-related phenotypes. From this
multi-cohort exploratory study we provide further evidence for the
well-reported associations between the SNP and triglycerides,
investigate several novel associations, including those with lung
function, physical and cognitive capability, as well as explore
interactions between the SNP and physical activity and sex on
these measures.
Methods
Ethics Statement
Informed consent was obtained from all participants. Ethical
approval was obtained from the South-east Multi-centre Research
Ethics Committee, the North Thames Multi-centre Research
Ethics Committee, the Joint UCL/UCLH Committees on the
Ethics of Human Research (Committee Alpha), the Medical
Research and Ethics Committee, and the Lothian Research Ethics
Committee.
Study Populations
The National Child Development Study (NCDS) follows
individuals from all births in England, Scotland and Wales during
1 week in March 1958. In 2002–04 a Biomedical Survey was
conducted during home visits by a research nurse. Following
informed consent, DNA was extracted from 8017 participants
aged 44–45 years; the sample with immortalised cell line culture
(n = 7526) is used here. In 2008–09, an eighth sweep was carried
out during which cognitive performance tests were conducted
[35]. Further details of the study are available on the cohort’s
genetic information website (http://www.b58cgene.sgul.ac.uk/)
and elsewhere [36].
The Medical Research Council National Survey of Health and
Development (NSHD) comprises participants sampled from all
births in a week in March 1946 and followed up since. In 1999, at
age 53 years, men and women were visited by a research nurse
and consent for DNA extraction was given by approximately 2900
members of the cohort. Details of the data collected and the
several phases of the study are available on the cohort’s website
(www.nshd.mrc.ac.uk) and elsewhere [37].
The Whitehall II study targeted all civil servants aged between
35 and 55 years working in London in 1985–88. In 2002–04
(Phase 7), the genetics study was established and DNA was
extracted from 6156 participants. Details of the study design and
data collected have been described elsewhere [38].
The English Longitudinal Study of Ageing (ELSA) comprises
men and women aged 50 years and over who originally
participated in the Health Survey for England in 1998, 1999 or
2001. Fieldwork began in 2002–03 (Phase I) with two-yearly
follow-ups and in 2004–05 (Phase II) blood samples were provided
by 6231 participants. Details of the cohort have been published
elsewhere [39].
The Lothian Birth Cohort 1921 (LBC1921) participants were all
born in 1921 and most completed a cognitive ability assessment at
age 11 years. In 1999–2001 (Wave I), at approximately 79 years
old, 550 participants living in and around Edinburgh, underwent a
series of cognitive and physical tests. Details of the recruitment into
the study are available on its website (www.lothianbirthcohort.ed.
ac.uk) and have been published previously [40,41].
Genotyping and Quality Control
Genotype information for GCKR rs1260326 (P446L) came from
various sources. In NCDS, information came from both the
GCKR and Age-Related Phenotypes
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Illumina HumanHap550K v3 and Illumina 1.2 M chips (www.
illumina.com) [42]. Data in NSHD and Whitehall II came from
the Illumina Metabochip. In ELSA, the closest available proxy was
used; SNP rs780094, in very strong linkage disequilibrium
(r2 = 0.93; 1000 Genomes Pilot 1, CEU population), was obtained
via the Applied Biosystems SNPlex 48-plex SNP genotyping
system. Information for LBC1921 came from the Illumina Human
610-Quadv1 Chip [43]. Departure from the Hardy-Weinberg
equilibrium was assessed in all studies using the chi-square test.
Phenotypes
Anthropometry and biological function. Several measures
of anthropometry and biological function were used, where
available in the cohorts. Body mass index (BMI kg/m2) was
calculated as weight divided by height squared derived from
measurements conducted at clinics, during a clinical interview in
the home, or from self-report. Waist-hip ratio (WHR) was defined
as waist circumference (cm) divided by hip circumference (cm).
Sitting systolic blood pressure (SBP), diastolic blood pressure (DBP)
(mmHg) and pulse rate (BPM) were recorded at the clinical
interview; where more than one measurement was taken the mean
values were used in analysis. Spirometry was used to assess lung
function: forced vital capacity (FVC) and forced expiratory volume
(FEV) in 1s (L); the highest value was used in the analyses. Blood
samples were used to measure fibrinogen (g/L), total, low-density
lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol
(mmol/L), triglycerides (mmol/L), fasting glucose (mmol/L) and
non-fasting glycosylated hemoglobin (HbA1c, %).
Cognitive capability. A number of cognitive performance
tests in the different studies were used to assess cognitive capability.
Different assessments of verbal memory were conducted: in ELSA
and NCDS, a list of 10 common words were used, with
participants asked to recall the list immediately and again after a
delay, the mean score was used in the analysis; in NSHD, 15
words were used over three trials; in Whitehall II 20 words were
used; responses in NSHD and Whitehall II were given in writing.
In Whitehall II, participants recalled in writing in 1 min as many
words as possible beginning with ‘S’ to assess phonemic fluency,
while in LBC1921 three letters ‘C’, ‘F’ and ‘L’ were used with
responses given orally. Participants were asked to recall as many
animals as possible within 1 min to measure semantic fluency;
responses were given orally in ELSA, NCDS and NSHD, and in
writing in Whitehall II. To assess search speed [44], 1-min letter
searches among grids of letters were used; 600 letters in NSHD
and 780 in ELSA and NCDS.
Physical capability and activity. Grip strength was mea-
sured in NSHD, ELSA and LBC1921 using electronic or
hydraulic dynamometers, with the best measure used in the
analysis where more than one trial was conducted. Speeds were
calculated from timed walks over 2.44 m (8 feet) and 6 m carried
out in ELSA and LBC1921 respectively, with the fastest speed
used in the analysis where more than one trial was conducted.
Timed chair rises [45] involved asking participants to rise from a
chair and sit back down 5 times in ELSA and 10 times in NSHD;
the reciprocal of time taken in seconds6100 [46] was used in the
analysis. Standing balance tests were conducted with participants’
eyes open using the Flamingo Balanace Test [47] (stopped at 30 s)
in NSHD and the side-by-side, semi-tandem and full tandem [48]
in ELSA. Poor standing balance was defined for this analysis as the
inability to complete 5 s. Further details of these measurements in
these cohorts are presented elsewhere [49]. Levels of physical
activity were derived from self-reported levels using question-
naires. Individuals were categorised as ‘physically active’ in this
analysis if they engaged in at least moderate sport or activities at
least monthly in NCDS, NSHD and LBC1921, or vigorous sport
or activities at least monthly in ELSA or at least weekly in
Whitehall II.
Statistical Methods
Where information on ethnicity was collected, non-European
participants were excluded from analyses in order to avoid
confounding from population stratification [50]. Within studies,
linear and logistic regression analyses were conducted on the
continuous and dichotomous traits within the cohorts respectively,
adjusting for age in the age heterogeneous cohorts of ELSA and
Whitehall II, as well as sex. Given the strong associations with
triglycerides [12,13], in a second model, measures were addition-
ally adjusted for it, as well as height and weight, except when
testing for the associations with height, weight, BMI and
triglycerides. Additive models were used with genotypes coded as
0, 1 and 2 for the number of minor alleles. Likelihood ratio tests
were used to compare the fit of the additive models compared with
the full genotype models. For continuous traits, the normality of
the standardised residuals was inspected with distributional
diagnostic plots. For the harmonisation of continuous traits that
were used to obtain pooled estimates of the genotypic effects, z-
score units were calculated in each study by subtracting the study
mean and dividing by its standard deviation. The overall mean for
z-scores is 0 and standard deviation 1. Two-step [51] meta-
analyses using a random-effects model were performed to obtain
pooled genotypic effects. The I2 measure was used to quantify
heterogeneity [52]. Additionally, meta-analyses of the interaction
terms in the second model between the SNP and physical activity,
as well as between the SNP and sex were conducted for all
outcome measures. Reporting of the analyses met the appropriate
items of recommended checklists [53,54]. A two-tailed significance
level of p,0.05 was used as evidence of statistical significance.
Statistical analysis was performed in Stata 11.2 (StataCorp LP).
Quanto [55] was used for power calculations using the overall
minor allele frequency (MAF) of 0.39.
Results
Cohort Summaries and Genotyping Quality
Of the 17,004 participants with valid genotypic data, 753 (4.4%)
were excluded due to missing values of height, weight and
triglycerides, leaving 16,251, as presented in Table 1. Similar
genotypic frequencies were observed across the studies and the
HWE condition was met for both sources of the NCDS data, as
well as for all other studies (p-values.0.07), except NSHD (p-
value = 0.03).
Associations between Genotype and Phenotypes
Results of the investigations between the SNP and measures of
anthropometry and biological function are presented in Table 2
and Table S1. Evidence of associations in the pooled analyses
between the SNP and measures of anthropometry were only
observed after adjusting for triglycerides, with the T allele being
associated with lower weight and BMI (Figure S1). The T allele
was also associated with lower WHR after adjusting for age, sex
and triglycerides (p-value = 0.002; data not shown), though this
association no longer remained after additional adjustment for
height and weight (Table 2). There was no evidence for
associations between the GCKR genotype and measures of blood
pressure or pulse rate from the pooled results of either model (p-
values.0.2; Table 2 and Table S1). There was some evidence that
the T allele was associated with higher FVC, after additional
adjustment for height, weight and triglycerides (Table 2, Table S1,
GCKR and Age-Related Phenotypes
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Figure S2), though there was heterogeneity in the associations with
FEV. Evidence for an association between the T allele and
increased HDL cholesterol was apparent in the second model
(Figure S3), with evidence for heterogeneity among the studies.
There was very strong evidence for an association between the T
allele and higher levels of triglycerides, which strengthened after
adjustment for body size (p-value = 3610211; Figure S4). Associ-
ations between the T allele and lower glucose were also stronger in
the second model (Figure S5). There was no evidence for
associations between the SNP and fibrinogen or LDL cholesterol
(p-values.0.1).
No genotypic associations were observed for any of the cognitive
capability traits in the pooled analyses (p-values.0.1; Table 3), or
for any of the measures of physical capability (p-values.0.1;
Table 4). Additional adjustment for glucose did not materially
change the null associations observed for the cognitive and
physical capability measures (data not shown).
In only a relatively small number of tests did the per allele
model represent a significantly poorer fit than the full genotype
model (indicated in Table 3 and Table S1).
Interactions between Genotype and Physical Activity
There was suggestive evidence that physical activity attenuated
the negative association between the minor allele and weight
towards the null (pooled p-value for interaction terms for
weight = 0.07, Figure S6; BMI p-value= 0.1, data not shown) with
effects only observed in the physically inactive individuals when
analysed separately (pooled beta for weight z-score =20.06,
p-value= 0.0001, n= 8289 in inactive; beta =20.02, p-value= 0.1,
n= 7854 in active; data not shown). There was also suggestive
Table 1. Summary of Sex, Age and GCKR Genotype Frequencies by Cohort.
Cohort Male (%) Age* in years, C/C C/T T/T Total
median (range) n (%) n (%) n (%)
NCDS 50 44 1901 (36.4) 2513 (48.1) 808 (15.5) 5222
NSHD 47 53 819 (35.8) 1141 (49.8) 329 (14.4) 2289
Whitehall II 77 59 (50–73) 1110 (35.3) 1535 (48.8) 502 (16.0) 3147
ELSA" 46 64 (52–90+) 1922 (37.7) 2438 (47.8) 736 (14.4) 5096
LBC1921 42 79 (77–80) 195 (39.2) 230 (46.3) 72 (14.5) 497
Total 54 53 (44–90+) 5947 (36.6) 7857 (48.3) 2447 (15.1) 16251
*Age at phase from which the majority of variables are taken, i.e. ELSA: II; LBC1921: I; NCDS: Biomedical Survey (2002); NSHD: 1999 Collection; Whitehall II: VII. ELSA:
English Longitudinal Study of Ageing; NCDS: National Child Development Study; NSHD: National Survey of Health and Development.
"rs780094 in ELSA, r2 = 0.93 with rs1260326.
doi:10.1371/journal.pone.0070045.t001
Table 2. Anthropometry and Biological Function by GCKR Genotype (Pooled Results).
Model 1* Model 2**
Variable Total Beta (95% CI) p I2%; Het p Beta (95% CI) p I2%; Het p
Height, cm 16251 20.011 (20.030–0.007) 0.23 24.6; 0.26 0.006 (20.011–0.023) 0.48 23.7; 0.26
Weight, kg 16251 20.018 (20.047–0.011) 0.23 45.1; 0.12 20.040 (20.061–20.020) 0.0001 15.9; 0.31
BMI, kg/m2 16251 20.011 (20.041–0.019) 0.48 37.1; 0.17 20.045 (20.067–20.022) 0.0001 7.4; 0.36
Waist-hip ratio 15680 0.006 (20.011–0.022) 0.51 0.0; 0.51 20.010 (20.024–0.004) 0.15 0.0; 0.77
Systolic blood pressure, mmHg 15630 0.007 (20.027–0.041) 0.67 51.9; 0.08 20.002 (20.035–0.032) 0.92 52.8; 0.08
Diastolic blood pressure, mmHg 15630 0.003 (20.035–0.042) 0.87 61.3; 0.035 20.003 (20.041–0.036) 0.90 63.6; 0.027
Pulse rate, BPM 11990 20.003 (20.028–0.022) 0.80 0.0; 0.55 20.015 (20.039–0.010) 0.24 0.0; 0.42
Forced vital capacity, L 12587 0.013 (20.006–0.032) 0.19 0.0; 0.64 0.022 (0.005–0.039) 0.013 0.0; 0.49
Forced expiratory volume, L 12588 0.019 (20.012–0.051) 0.23 51.5; 0.10 0.030 (20.005–0.065) 0.09 65.0; 0.036
Fibrinogen, g/L 13530 0.020 (20.011–0.050) 0.21 30.9; 0.23 0.019 (20.008–0.046) 0.16 15.7; 0.31
Total cholesterol, mmol/L 16251 0.052 (0.019–0.084) 0.0018 47.6; 0.11 0.013 (20.018–0.045) 0.41 51.2; 0.08
HDL cholesterol, mmol/L 15575 0.000 (20.037–0.037) 0.98 64.3; 0.038 0.042 (0.003–0.081) 0.033 75.0; 0.007
Log triglycerides, mmol/L 16251 0.105 (0.064–0.147) 6.261027 67.4; 0.015 0.112 (0.079–0.145) 2.8610211 54.9; 0.064
LDL cholesterol, mmol/L 15128 20.004 (20.027–0.019) 0.75 0.0; 0.73 20.018 (20.041–0.005) 0.12 0.0; 0.90
Glucose" 14106 20.042 (20.066–20.018) 0.0007 0.0; 0.60 20.056 (20.080–20.033) 2.661026 0.0; 0.74
Het- heterogeneity. Beta coefficients per T allele based on z-scores.
*Adjusted for age and sex.
**Additional adjustments: i) height model: weight and triglycerides; ii) weight model: height and triglycerides; iii) triglycerides model: height and weight; iv) BMI model:
triglycerides; v) all other models: height, weight and triglycerides.
"Glucose in mmol/L or HbA1c in %.
doi:10.1371/journal.pone.0070045.t002
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Table 3. Cognitive Capability by Cohort and GCKR Genotype.
Model 1* Model 2**
Variable Cohort Mean (SD) [n] Beta (95% CI) p I2%; Het p Beta (95% CI) p I2%; Het p
Word recall- 10 words NCDS 6.0 (1.5) [5159] 0.00 (20.04–0.04) 0.85 0.01 (20.03–0.04) 0.79
Word recall- 45 words NSHD 23.9 (6.3) [2235] 0.05 (20.01–0.12) 0.08 0.07 (0.01–0.13) 0.0324
Word recall- 20 words Whitehall II 7.0 (2.4) [3103] 20.03 (20.08–0.02) 0.25 20.02 (20.07–0.02) 0.33
Word recall- 10 words ELSA 5.0 (1.7) [5044] 0.02 (20.02–0.06) 0.31 0.03 (20.01–0.06) 0.16
Pooled [15541] 0.010 (20.019–0.038) 0.50 37.6; 0.19 0.016 (20.016–0.047) 0.33 48.5; 0.12
Phonemic fluency- 1 letter Whitehall II 16.0 (4.1) [3093] 0.03 (20.02–0.08) 0.20 0.04 (20.01–0.09) 0.11
Phonemic fluency- 3 letters LBC1921 40.5 (12.1) [494] 0.01 (20.12–0.14) 0.84 20.00 (20.13–0.13) 0.99
Pooled [3587] 0.030 (20.016–0.077) 0.20 0.0; 0.78 0.035 (20.012–0.082) 0.14 0.0; 0.56
Semantic fluency NCDS 22.5 (6.3) [5189] 20.01 (20.05–0.03) 0.67 20.01 (20.05–0.03) 0.73
NSHD 23.7 (6.8) [2275] 0.00 (20.06–0.06) 0.96 0.01 (20.05–0.07) 0.80
Whitehall II 16.0 (3.7) [3103] 0.00 (20.05–0.05) 0.90 0.01 (20.04–0.06) 0.63
ELSA 20.3 (6.1) [5047] 0.03 (20.01–0.07) 0.14 0.03 (20.00–0.07) 0.08
Pooled [15614] 0.008 (20.014–0.030) 0.49 0.0; 0.59 0.013 (20.009–0.035) 0.26 0.0; 0.53
Search speed- 780 letters NCDS 333 (86) [5089] 0.01 (20.03–0.05) 0.60 0.01 (20.03–0.05) 0.59
Search speed- 600 letters NSHD 282 (76) [2264] 0.00 (20.06–0.06){ 0.95 0.01 (20.05–0.07) 0.73
Search speed- 780 letters ELSA 300 (90) [4990] 0.01 (20.03–0.05) 0.74 0.01 (20.03–0.05) 0.58
Pooled [12343] 0.007 (20.018–0.033) 0.57 0.0; 0.97 0.011 (20.014–0.036) 0.39 0.0; .0.99
Het- heterogeneity. Beta coefficients per T allele based on z-scores. NCDS: Sweep 8 (2008).
*Adjusted for age and sex.
**Additionally adjusted for height, weight and triglycerides in all models.
{Full genotype model representing a significantly better fit than the given per allele model.
doi:10.1371/journal.pone.0070045.t003
Table 4. Physical Capability by Cohort and GCKR Genotype.
Model 1* Model 2**
Variable Cohort Mean (SD) [n] Beta (95% CI) p I2%; Het p Beta (95% CI) p I2%; Het p
Grip strength, kg NSHD 37.8 (14.4) [2206] 20.01 (20.05–0.04) 0.77 0.00 (20.04–0.05) 0.84
ELSA 32.2 (11.5) [5053] 20.00 (20.03–0.02) 0.86 0.00 (20.02–0.03) 0.82
LBC1921 26.7 (9.1) [497] 20.06 (20.14–0.02) 0.16 20.06 (20.14–0.02) 0.14
Pooled [7756] 20.007 (20.027–0.014) 0.53 0.0; 0.44 20.002 (20.025–0.021) 0.87 11.8; 0.32
Timed 2.44 m
walk, m/s
ELSA 0.94 (0.29) [3222] 0.03 (20.01–0.08) 0.17 0.05 (20.00–0.09) 0.05
Timed 6 m
walk, m/s
LBC1921 1.41 (0.37) [494] 0.01 (20.12–0.13) 0.92 20.02 (20.15–0.10) 0.69
Pooled [3716] 0.029 (20.014–0.073) 0.19 0.0; 0.69 0.034 (20.015–0.084) 0.17 8.4; 0.30
Timed chair
rises"-10 rises
NSHD 5.2 (1.7) [2148] 0.01 (20.05–0.08) 0.69 0.01 (20.05–0.07) 0.76
Timed chair
rises"-5 rises
ELSA 9.7 (3.1) [4472] 0.02 (20.02–0.06) 0.24 0.03 (20.01–0.07) 0.17
Pooled [6620] 0.021 (20.013–0.054) 0.23 0.0; 0.77 0.022 (20.011–0.056) 0.19 0.0; 0.64
Variable Cohort Total n (%){ OR (95% CI) p I2%; Het p OR (95% CI) p I2%; Het p
Balance ,5s-One
legged
NSHD 87 (3.9) 1.15 (0.84–1.58) 0.37 1.18 (0.86–1.62) 0.32
Balance ,5s-Tandem ELSA 573 (11.2) 0.96 (0.84–1.10) 0.58 0.94 (0.81–1.08) 0.35
Pooled [660/7326] 0.995 (0.865–1.144) 0.94 7.9; 0.30 1.001 (0.816–1.229) 0.99 39.7; 0.20
Het- heterogeneity. Beta coefficients per T allele based on z-scores.
*Adjusted for age and sex.
**Additionally adjusted for height, weight and triglycerides in all models.
"Reciprocal of time taken in sec6 100.
{Data within cohorts represent the number (%) of participants unable to balance for at least 5s. Data for pooled row represent the number of participants unable to
balance for at least 5s/number of participants who performed the test.
doi:10.1371/journal.pone.0070045.t004
GCKR and Age-Related Phenotypes
PLOS ONE | www.plosone.org 5 July 2013 | Volume 8 | Issue 7 | e70045
evidence that the raising effects of the minor allele on log-
transformed triglycerides was larger among the physically inactive
individuals by around 0.04 z-score units (pooled p-value for
interaction terms= 0.06; Figure S7). Figure S8 shows evidence for
different genotypic effects in the two groups on LDL cholesterol
(pooled p-value for interaction terms= 0.04), with a negative effect
of the minor allele observed in the physically active group when
analysed separately (pooled beta for LDL cholesterol z-score = 0.01,
p-value= 0.7, n= 7725 in inactive; beta =20.04, p-value= 0.008,
n= 7364 in active; data not shown). There was no evidence that the
genotypic effects on the other measures differed by physical activity
status (p-values.0.09, data not shown).
Interactions between Genotype and Sex
Figures S9 and S10 show that there is evidence that the effects
of the genotype on SBP and DBP differed by sex (pooled p-value
for interaction terms= 0.002 and 0.005, respectively), with a
lowering effect of the minor allele observed in males but not
females when analysed separately (e.g. pooled beta for SBP z-
score =20.04, p-value = 0.01, n = 8431 in males; beta = 0.04, p-
value = 0.1, n= 7199 in females; data not shown). There was also
evidence for an interaction between the genotype and sex on FEV,
fibrinogen and phonemic fluency (pooled p-values for interaction
terms= 0.04, 0.01 and 0.01, respectively; Figures S11 to S13),
though in neither sex did the effects reach statistical significance.
Discussion
We examined associations between the functional [11] GCKR
SNP rs1260326 (P446L) and several age-related phenotypes,
including previously investigated cardiometabolic biomarkers as
well as novel investigations into other phenotypes including
measures of cognitive and physical capability, in 16,251 men
and women aged between 44 and 90+ years from five UK cohorts.
We confirmed the well-reported associations between the minor
(T) allele of the SNP and higher levels of triglycerides and lower
levels of glucose. In addition, we observed an association between
the allele and lower weight and BMI, as well as higher FVC and
HDL, which was only apparent after adjusting for triglycerides. A
stronger association with glucose was observed after triglyceride
adjustment. Despite the reported associations with a range of
biomarkers [12,13,15–20], we found no strong evidence for
associations between the SNP and our other age-related pheno-
types, including measures of grip strength and verbal memory.
Our investigation into interactions between the genotype and self-
reported physical activity on our phenotypes provide further
evidence for a possible reduction in the genotypic effect on
triglycerides in physically active individuals [25], a reduction in
triglyceride-adjusted LDL cholesterol in active individuals, as well
as evidence for the triglyceride-adjusted effect on weight occurring
in physically inactive individuals only. We also found evidence for
sex differences in the genotypic effects on SBP and DBP with
reduced effects of the T allele only observed in males. These
findings may provide insight into the mechanisms of GCKR on
various phenotypes and should encourage the continued explora-
tion into the modifiers of the genotypic effects of this and other
genes.
GWAS and candidate gene studies have identified SNPs in
GCKR that are strongly associated with a range of traits. In
particular, there is very strong evidence that the T allele of
rs1260326 is associated with increased levels of triglycerides
[12,13], CRP [15] and lower glucose [10], however there is
disagreement among previous reports regarding the associations
for some other phenotypes. For instance, many studies including
one conducted in 4363 Europeans [21] found no association
between the SNP and BMI and WHR, whereas an investigation
into 2900 Han Chinese older adults found an association between
the T allele and lower BMI and waist circumference [56] which,
unlike in our study, was apparent before adjustment for
triglycerides. Furthermore, differences have been reported for
SNPs in the gene regarding associations with apolipoprotein B
[12,13], LDL [14,57] and HDL cholesterol [14,58]. With respect
to the latter, similar to our findings, a positive association with the
minor allele of rs780094 (r2 with rs1260326 is 0.93) and HDL
cholesterol was observed only after adjusting for triglycerides in a
study of around 10,000 middle-aged adults [59]; suggesting the
very strong association with triglycerides may be confounding
associations between SNPs in the gene and other traits. Our
findings for differential genotypic effects on triglycerides, LDL
cholesterol and weight by physical activity status are in line with
other reports that suggest that physical activity can modify genetic
effects [60,61] and, along with confounding by triglycerides, may
provide insight into the contributing factors for the mixed reports
for associations of SNPs in GCKR on phenotypes. We also found
evidence for an interaction between the GCKR genotype and sex
on SBP and DBP, though, a large multi-study investigation
comprising over 34,000 individuals of European ancestry found no
association between SNP rs780094 and SBP and DBP [58],
however, further investigations into these associations by sex are
required to determine whether our findings in males are true
associations.
To the best of our knowledge, this is the first report of an
investigation between SNPs in GCKR and measures of lung
function, physical and cognitive capability. The null associations
observed for physical and cognitive capability, both before and
after adjustment for triglycerides, glucose, and body size, in either
sex or physical activity group, from our large multi-cohort study
provides evidence against the importance of the gene to ageing
beyond cardiometabolic biomarkers and weight. Sample size
calculations determined that we were well-powered to detect
reasonably small effects on quantitative traits. For example,
around 5000 individuals would be required to detect a beta
coefficient of 0.06 z-score units with 80% power at the 5%
significance level, corresponding to a difference in semantic
fluency of around 0.7 points between the two homozygote groups,
assuming a standard deviation of 6, or around 1.3 kg in grip
strength, assuming a standard deviation of 11. Whilst further
larger investigations into the measures of cognitive and physical
capability could reveal some associations, our study did not
provide evidence for an effect of GCKR rs1260326 on these traits.
Therefore, GCKR appears not to be a common cause of ageing
from the phenotypes we investigated and, as yet, there appear to
be very few examples of genes that independently influence a
range of diverse ageing domains.
As adjusting for triglycerides revealed further or stronger
associations for the SNP with some traits, the lack of availability
of other biomarkers in our study may mean that we have missed
the identification of further associations. For example, a triglyc-
eride-independent effect on CRP has been observed [25] and
relationships between inflammatory biomarkers of ageing and
cognitive capability have been hypothesised [26]. Therefore,
further investigations into cognitive and physical capability in
studies that can adjust for other biomarkers may be useful.
Conclusion
The results of this large multi-cohort study of middle-aged to
older adults confirm associations between the functional GCKR
GCKR and Age-Related Phenotypes
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SNP rs1260326 (P446L) and triglycerides and glucose, suggest an
environmentally modifiable effect on triglycerides, LDL and
weight, but do not provide evidence for its relevance to other
ageing phenotypes, such as grip strength and verbal memory.
Supporting Information
Figure S1 Meta-analysis for the Associations between
GCKR Genotype and BMI. Adjusted for age, sex and
triglycerides. Coefficients based on z-scores.
(TIF)
Figure S2 Meta-analysis for the Associations between
GCKR Genotype and FVC. Adjusted for age, sex, height,
weight and triglycerides. Coefficients based on z-scores.
(TIF)
Figure S3 Meta-analysis for the Associations between
GCKR Genotype and HDL Cholesterol. Adjusted for age,
sex, height, weight and triglycerides. Coefficients based on z-
scores.
(TIF)
Figure S4 Meta-analysis for the Associations between
GCKR Genotype and Log Triglycerides. Adjusted for age,
sex, height and weight. Coefficients based on z-scores.
(TIF)
Figure S5 Meta-analysis for the Associations between
GCKR Genotype and Glucose. Adjusted for age, sex, height,
weight and triglycerides. Coefficients based on z-scores. HbA1c(%)
in NCDS, NSHD and LBC1921; glucose (mmol/L) in Whitehall
II and ELSA.
(TIF)
Figure S6 Meta-analysis for the Interaction between
GCKR Genotype and Physical Activity on Weight.
Adjusted for age, sex, height and triglycerides. Coefficients based
on z-scores. Comparing participants defined as physically active to
those physical inactive.
(TIF)
Figure S7 Meta-analysis for the Interaction between
GCKR Genotype and Physical Activity on Log Triglycer-
ides. Adjusted for age, sex, height and weight. Coefficients based
on z-scores. Comparing participants defined as physically active to
those physical inactive.
(TIF)
Figure S8 Meta-analysis for the Interaction between
GCKR Genotype and Physical Activity on LDL Choles-
terol. Adjusted for age, sex, height, weight and triglycerides.
Coefficients based on z-scores. Comparing participants defined as
physically active to those physical inactive.
(TIF)
Figure S9 Meta-analysis for the Interaction between
GCKR Genotype and Sex on Systolic Blood Pressure.
Adjusted for age, height, weight and triglycerides. Coefficients
based on z-scores. Comparing females to males.
(TIF)
Figure S10 Meta-analysis for the Interaction between
GCKR Genotype and Sex on Diastolic Blood Pressure.
Adjusted for age, height, weight and triglycerides. Coefficients
based on z-scores. Comparing females to males.
(TIF)
Figure S11 Meta-analysis for the Interaction between
GCKR Genotype and Sex on FEV. Adjusted for age, height,
weight and triglycerides. Coefficients based on z-scores. Compar-
ing females to males.
(TIF)
Figure S12 Meta-analysis for the Interaction between
GCKR Genotype and Sex on Fibrinogen. Adjusted for age,
height, weight and triglycerides. Coefficients based on z-scores.
Comparing females to males.
(TIF)
Figure S13 Meta-analysis for the Interaction between
GCKR Genotype and Sex on Phonemic Fluency. Adjusted
for age, height, weight and triglycerides. Coefficients based on z-
scores. Comparing females to males.
(TIF)
Table S1 Anthropometry and Biological Function by
GCKR Genotype (Full Results). Het- heterogeneity. Beta
coefficients per T allele based on z-scores. *Adjusted for age and
sex. **Additionally adjusted for height, weight and triglycerides in
all models, except: i) height- weight and triglycerides, ii) weight-
height and triglycerides, iii) triglycerides-height and weight. {Full
genotype model representing a significantly better fit than the
given per allele model. Whitehall II: fibrinogen from Phase V.
(DOC)
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